Remove Doctors Remove Therapies Remove Treatment Remove Trials
article thumbnail

Phase II trial investigates allogeneic CAR-T for large B-cell lymphoma

Drug Discovery World

Allogene Therapeutics and Foresight Diagnostics have announced the initiation of a Phase II trial evaluating the use of cemacabtagene ansegedleucel (cema-cel) as part of the first line treatment regimen for newly diagnosed large B-cell lymphoma (LBCL) patients who are likely to relapse.

Trials 147
article thumbnail

How to advance AAV-based gene therapies

Drug Discovery World

Sara Donnelly, Director of Research Planning and Business Development at PhoenixBio USA explores why the right pre-clinical model is essential for teams wanting to advance adeno-associated virus vector-based gene therapies. Adeno-associated virus (AAV) vector-based gene therapies hold exceptional promise across a range of disease areas.

Therapies 162
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Genetic biomarkers could personalise therapy for TNBC

Drug Discovery World

The study, by researchers at The Institute of Cancer Research, London, shows that certain characteristics within patients’ primary tumours can predict how they will respond to different treatments after their tumours have spread around the body.

Therapies 130
article thumbnail

Combination therapy halts lung cancer tumour growth in mice

Drug Discovery World

A pathway to better therapies. The findings suggest a pathway to better therapies for one of the least treatable forms of cancer. The problem is that these tumours respond to treatment initially, but then they come back. Phase I trial on the horizon. Hindering this repair process makes the drug much more effective. .

Therapies 130
article thumbnail

Researcher’s Perspectives: How a personal connection created a career in clinical trials

Antidote

Behind every new treatment is the incredible team of doctors, researchers, patients, and clinical trial specialists who worked on the research that made it possible.

article thumbnail

Immuno-oncology innovations redefining cancer treatment in 2024

Drug Target Review

What innovative approaches and technologies are anticipated to reshape immuno-oncology treatments in 2024? Immuno-oncology, notably through checkpoint inhibitors, has significantly reshaped cancer treatment over the past decade.

Treatment 122
article thumbnail

Medicinal cannabis: Why more clinical trials and better access is needed

Drug Discovery World

Big pharma is helping to shape the focus The good news is that clinical trials are on the increase and market education is upping pace. Meanwhile, the Pfizer purchase of Arena Pharmaceuticals, highlights cannabinoid-based bowel disease treatments as a promising area.